Researchers are exploring whether AI can improve embryo selection, but experts say more evidence is needed before it becomes standard practice.

WHAT’S HAPPENING

Fertility clinics are increasingly testing AI to assist with IVF procedures, particularly in evaluating embryo quality and predicting which embryos are most likely to result in a successful pregnancy. Early studies suggest AI can outperform traditional visual assessments in some areas, but researchers caution that there is not yet enough evidence to show it consistently improves live birth rates.

WHY IT MATTERS

IVF remains an expensive and emotionally challenging process for many families. If AI can help identify the most viable embryos or improve treatment decisions, it could increase efficiency and potentially improve outcomes. At the same time, questions remain about privacy, bias, ethics, and whether AI should influence decisions involving genetic traits.

WHO BENEFITS

• Patients undergoing fertility treatment.
• Fertility clinics seeking better diagnostic tools.
• Researchers developing AI-powered reproductive medicine.

WHO LOSES

• Patients expecting AI to guarantee better outcomes.
• Healthcare providers if AI systems are adopted before sufficient clinical validation.

WHAT HAPPENS NEXT

Researchers are calling for larger clinical trials to determine whether AI can consistently improve IVF success rates. Until stronger evidence emerges, most experts expect AI to serve as a decision-support tool alongside fertility specialists rather than replace human expertise.